Otherwise, concomitant antihyperlipidemic agents such as fibrates and statins used in patients with dyslipidemia and insulins and insulin-release agents used in patients with DM may have controlled causal hypertriglyceridemia to such low levels that they do not trigger pancreatitis [23], [24]. This evidence concerns the gene INS and metabolic syndrome.